Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Amanda E YungGareth CrouchAlexander H R VareySerigne LoMichael S ElliottJenny LeeRobert RawsonRuta GuptaAngela M HongJonathan R ClarkSydney Ch'ng

Published in: Annals of surgical oncology (2022)

More than 60% of patients treated surgically for pT3/4 head and neck cSCC were alive and free of disease at 5 years posttreatment. High-risk features such as margin involvement and having had previous treatment (radiotherapy/surgery) should be used to guide adjuvant therapy.

Keyphrases

squamous cell carcinoma
minimally invasive
early stage
coronary artery bypass
radiation therapy
radiation induced
replacement therapy
atrial fibrillation